Variant report

Variant	rs12492880
Chromosome Location	chr3:50309124-50309125
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:79)
CpG islands
(count:0)
Chromatin interactive
region (count:19)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:79 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr3:50308555-50309393	HepG2	liver:	n/a	n/a
2	GTF2F1	chr3:50308851-50309346	Hela-S3	cervix:	n/a	n/a
3	HDAC2	chr3:50308658-50309423	HepG2	liver:	n/a	n/a
4	NR2F2	chr3:50308657-50309460	MCF-7	breast:	n/a	n/a
5	GATA3	chr3:50308641-50309435	MCF-7	breast:	n/a	n/a
6	EP300	chr3:50308978-50309232	K562	blood:	n/a	n/a
7	SMARCB1	chr3:50305961-50309446	Hela-S3	cervix:	n/a	n/a
8	MAZ	chr3:50307867-50309382	Hela-S3	cervix:	n/a	n/a
9	NFIC	chr3:50308953-50309293	HepG2	liver:	n/a	n/a
10	POLR2A	chr3:50305179-50309393	HepG2	liver:	n/a	n/a
11	SMC3	chr3:50308946-50309207	HepG2	liver:	n/a	n/a
12	TBP	chr3:50308655-50309260	HepG2	liver:	n/a	n/a
13	TFAP2A	chr3:50308021-50309382	Hela-S3	cervix:	n/a	n/a
14	POLR2A	chr3:50305651-50309364	Hela-S3	cervix:	n/a	n/a
15	RCOR1	chr3:50307859-50309329	Hela-S3	cervix:	n/a	n/a
16	EP300	chr3:50308777-50309415	MCF-7	breast:	n/a	n/a
17	GATA3	chr3:50308978-50309224	T-47D	breast:	n/a	n/a
18	TCF12	chr3:50308808-50309379	MCF-7	breast:	n/a	n/a
19	TBP	chr3:50308309-50309406	Hela-S3	cervix:	n/a	n/a
20	MAX	chr3:50308201-50309302	Hela-S3	cervix:	n/a	n/a
21	EP300	chr3:50308807-50309413	MCF-7	breast:	n/a	n/a
22	MAX	chr3:50305764-50309483	HepG2	liver:	n/a	chr3:50307440-50307450 chr3:50306954-50306964
23	RAD21	chr3:50308843-50309403	Hela-S3	cervix:	n/a	n/a
24	CHD2	chr3:50308786-50309396	Hela-S3	cervix:	n/a	n/a
25	EP300	chr3:50308889-50309254	HepG2	liver:	n/a	n/a
26	MYBL2	chr3:50308837-50309358	HepG2	liver:	n/a	n/a
27	EP300	chr3:50308814-50309320	HepG2	liver:	n/a	n/a
28	MAFK	chr3:50308796-50309280	Hela-S3	cervix:	n/a	n/a
29	SIN3AK20	chr3:50308651-50309438	MCF-7	breast:	n/a	n/a
30	POLR2A	chr3:50307446-50309363	Hela-S3	cervix:	n/a	n/a
31	HCFC1	chr3:50305717-50309480	Hela-S3	cervix:	n/a	n/a
32	SP1	chr3:50308798-50309329	HepG2	liver:	n/a	chr3:50308997-50309007 chr3:50308997-50309007
33	HNF4G	chr3:50308674-50309309	HepG2	liver:	n/a	chr3:50308770-50308783
34	ZKSCAN1	chr3:50308368-50309169	Hela-S3	cervix:	n/a	n/a
35	MAX	chr3:50308163-50309363	Hela-S3	cervix:	n/a	n/a
36	EP300	chr3:50308692-50309465	HepG2	liver:	n/a	chr3:50308713-50308726
37	POLR2A	chr3:50305532-50313853	HepG2	liver:	n/a	n/a
38	POLR2A	chr3:50308519-50309516	HepG2	liver:	n/a	n/a
39	TCF7L2	chr3:50308229-50309365	Hela-S3	cervix:	n/a	n/a
40	CHD2	chr3:50309117-50309330	HepG2	liver:	n/a	n/a
41	CEBPB	chr3:50308790-50309307	MCF-7	breast:	n/a	chr3:50309008-50309025 chr3:50309011-50309023
42	CEBPB	chr3:50308289-50309401	Hela-S3	cervix:	n/a	chr3:50309008-50309025 chr3:50309011-50309023
43	MYC	chr3:50309064-50309167	HepG2	liver:	n/a	n/a
44	CEBPB	chr3:50308823-50309290	MCF-7	breast:	n/a	chr3:50309008-50309025 chr3:50309011-50309023
45	SMC3	chr3:50307999-50309448	Hela-S3	cervix:	n/a	n/a
46	RXRA	chr3:50308883-50309270	HepG2	liver:	n/a	chr3:50308939-50308952 chr3:50308939-50308952 chr3:50308940-50308951
47	POLR2A	chr3:50308710-50309133	ECC-1	luminal epithelium:	n/a	n/a
48	HNF4A	chr3:50308902-50309202	HepG2	liver:	n/a	chr3:50309086-50309101
49	FOXM1	chr3:50308762-50309473	MCF-7	breast:	n/a	n/a
50	MBD4	chr3:50308631-50309306	HepG2	liver:	n/a	n/a

No data

(count:19 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:50307758..50309576-chr3:50315443..50317608,2	MCF-7	breast:
2	chr3:50305661..50309418-chr3:50646590..50649218,4	MCF-7	breast:
3	chr3:50309059..50311667-chr3:50323698..50326427,2	K562	blood:
4	chr3:50262511..50266127-chr3:50309039..50312887,6	K562	blood:
5	chr3:50305641..50310504-chr3:50314554..50317584,4	K562	blood:
6	chr3:50263554..50267133-chr3:50306867..50310561,4	K562	blood:
7	chr3:50307655..50309252-chr3:50364731..50366964,2	MCF-7	breast:
8	chr3:50305234..50312110-chr3:50326257..50332221,8	MCF-7	breast:
9	chr3:50303839..50307896-chr3:50307992..50312285,6	K562	blood:
10	chr3:50296030..50318456-chr3:50318822..50339499,66	MCF-7	breast:
11	chr3:50272719..50274831-chr3:50308202..50310303,2	K562	blood:
12	chr3:50307238..50313479-chr3:50353130..50365794,18	MCF-7	breast:
13	chr3:50230717..50232832-chr3:50306481..50309139,3	MCF-7	breast:
14	chr3:50300460..50314689-chr3:50349154..50363682,34	MCF-7	breast:
15	chr3:50308810..50310913-chr3:50335251..50336783,2	MCF-7	breast:
16	chr3:50307506..50309682-chr3:50326891..50328959,3	K562	blood:
17	chr3:50307506..50309682-chr3:50327252..50328959,2	K562	blood:
18	chr3:50271706..50275857-chr3:50303511..50313889,17	MCF-7	breast:
19	chr3:50273331..50275965-chr3:50307293..50309702,3	K562	blood:

No data

Variant related genes	Relation type
SEMA3B	TF binding region
SEMA3B-AS1	TF binding region
ENSG00000068001	Chromatin interaction
ENSG00000114353	Chromatin interaction
ENSG00000012171	Chromatin interaction
ENSG00000186792	Chromatin interaction
ENSG00000114383	Chromatin interaction
ENSG00000114378	Chromatin interaction
ENSG00000114737	Chromatin interaction
ENSG00000214706	Chromatin interaction
ENSG00000243477	Chromatin interaction
ENSG00000179564	Chromatin interaction
ENSG00000114738	Chromatin interaction
ENSG00000232352	Chromatin interaction
ENSG00000114349	Chromatin interaction

Extended variants
information (count: 138 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:105)

rs_ID	r²[population]
rs11130248	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.95[MEX][hapmap];0.91[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs12054052	0.91[AMR][1000 genomes]
rs12054403	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.95[MEX][hapmap];0.91[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs12485286	0.87[AMR][1000 genomes];0.82[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs12485390	0.95[CHB][hapmap];0.95[JPT][hapmap];0.98[AMR][1000 genomes];0.82[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs12485909	0.95[CHB][hapmap];0.98[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.97[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12487392	0.94[AMR][1000 genomes]
rs12488235	0.97[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs12488302	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.95[MEX][hapmap];1.00[AMR][1000 genomes];0.82[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs12490809	0.90[JPT][hapmap];0.91[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12490837	0.83[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12491177	0.80[AMR][1000 genomes]
rs12492683	0.97[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs12493693	0.98[AMR][1000 genomes];0.82[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs12494414	0.91[CHB][hapmap];0.95[CHD][hapmap];0.91[JPT][hapmap];1.00[MEX][hapmap];0.98[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs12495261	0.91[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs12496815	0.91[AMR][1000 genomes];0.82[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs12497018	0.95[ASN][1000 genomes]
rs12498048	0.98[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs12629572	0.84[CHD][hapmap]
rs12632110	0.95[CHB][hapmap];0.93[CHD][hapmap];0.87[JPT][hapmap]
rs12721544	0.94[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs1989839	0.84[CHD][hapmap]
rs2006199	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.91[JPT][hapmap];0.95[MEX][hapmap];0.97[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2021734	0.88[AMR][1000 genomes]
rs2071203	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.95[MEX][hapmap];0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs2071204	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.95[MEX][hapmap];0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2071205	0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2071801	0.91[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs2071804	0.86[CHB][hapmap];0.95[JPT][hapmap];0.84[AMR][1000 genomes];0.82[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs2072053	0.92[AMR][1000 genomes]
rs2072054	0.83[CHD][hapmap];1.00[GIH][hapmap];1.00[MEX][hapmap];0.90[AMR][1000 genomes]
rs2073497	0.88[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2073499	0.84[CHD][hapmap]
rs2073500	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.91[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2229647	0.95[AMR][1000 genomes];0.82[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs2233474	0.84[CHD][hapmap]
rs2233476	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.95[MEX][hapmap];0.87[AMR][1000 genomes];0.82[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs2236940	0.95[CHB][hapmap];0.95[CHD][hapmap];1.00[JPT][hapmap];0.87[ASN][1000 genomes]
rs2236941	0.95[CHB][hapmap];0.95[CHD][hapmap];1.00[JPT][hapmap];0.88[ASN][1000 genomes]
rs2236943	0.98[AMR][1000 genomes];0.82[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs2236944	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.90[ASN][1000 genomes]
rs2236946	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.95[MEX][hapmap];0.88[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2236949	0.83[CHB][hapmap];0.94[JPT][hapmap];0.91[AMR][1000 genomes];0.87[ASN][1000 genomes]
rs2236950	0.81[CHD][hapmap];0.83[JPT][hapmap]
rs2236986	0.81[AMR][1000 genomes]
rs2269430	0.95[CHB][hapmap];0.91[JPT][hapmap];0.98[AMR][1000 genomes];0.82[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2269432	0.95[CHB][hapmap];1.00[JPT][hapmap];0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2269568	0.91[AMR][1000 genomes];0.82[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs2269569	0.82[ASN][1000 genomes]
rs2282750	0.98[AMR][1000 genomes];0.82[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs2282751	0.84[CHD][hapmap]
rs2285043	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.90[MEX][hapmap];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2285044	0.95[CHB][hapmap];1.00[JPT][hapmap];0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2298953	0.95[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.89[ASN][1000 genomes]
rs2298954	0.95[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.89[ASN][1000 genomes]
rs2624839	0.84[CHD][hapmap]
rs3213621	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.90[MEX][hapmap];0.86[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs35455589	0.95[CHB][hapmap];0.98[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.95[MEX][hapmap];0.91[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs35587949	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];0.95[JPT][hapmap];0.95[MEX][hapmap];0.88[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs3774736	0.86[AMR][1000 genomes]
rs3774739	0.81[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.83[JPT][hapmap];1.00[MEX][hapmap];0.94[AMR][1000 genomes]
rs3774741	0.94[AMR][1000 genomes]
rs3774748	0.94[AMR][1000 genomes]
rs3774752	0.86[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];0.94[AMR][1000 genomes]
rs3774753	0.95[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.81[MEX][hapmap];0.94[ASN][1000 genomes]
rs3774754	0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs3774755	0.95[CHB][hapmap];0.98[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.91[AMR][1000 genomes];0.82[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs4141060	0.81[CHD][hapmap]
rs4141407	0.95[CHB][hapmap];1.00[JPT][hapmap];0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs4688679	0.95[CHB][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.87[AMR][1000 genomes];0.82[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs4688682	0.95[CHB][hapmap];0.98[CHD][hapmap];1.00[GIH][hapmap];0.95[JPT][hapmap];1.00[MEX][hapmap];0.98[AMR][1000 genomes];0.82[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs4688683	0.86[AMR][1000 genomes];0.80[ASN][1000 genomes]
rs4688721	0.82[AMR][1000 genomes]
rs4688724	0.95[CHB][hapmap];1.00[JPT][hapmap];0.91[AMR][1000 genomes];0.82[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs4688725	0.82[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs4688728	0.90[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs4688732	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs4688733	0.85[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs4688734	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs4688736	0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs4688738	0.95[AMR][1000 genomes];0.94[ASN][1000 genomes]
rs4688741	0.95[CHB][hapmap];0.98[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.98[AMR][1000 genomes];0.82[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs4688742	0.98[AMR][1000 genomes];0.82[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs4688743	0.92[AMR][1000 genomes]
rs4688744	0.95[AMR][1000 genomes];0.82[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs4688746	0.85[JPT][hapmap];0.94[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs4688747	0.94[AMR][1000 genomes]
rs57944420	0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs57978992	0.98[AMR][1000 genomes];0.82[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs58137261	0.91[AMR][1000 genomes]
rs58181992	0.85[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs58191283	0.91[AMR][1000 genomes]
rs58648044	0.87[ASN][1000 genomes]
rs60276643	0.94[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs6776145	0.84[CHD][hapmap]
rs72932959	0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs72932987	0.88[AMR][1000 genomes];0.82[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs7645537	0.95[CHB][hapmap];0.98[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.90[MEX][hapmap];0.95[AMR][1000 genomes];0.82[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs9311449	0.88[AMR][1000 genomes];0.82[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs9681992	0.90[AMR][1000 genomes];0.83[ASN][1000 genomes]
rs9830408	0.95[CHB][hapmap];1.00[JPT][hapmap];0.92[ASN][1000 genomes]
rs9852677	0.82[CHB][hapmap];0.95[CHD][hapmap];0.95[JPT][hapmap]
rs9882618	0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs9883222	0.95[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.86[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:33 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1001775	chr3:50129479-50311666	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
2	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
3	nsv1013949	chr3:50151712-50339163	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
4	nsv590250	chr3:50153356-50332697	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
5	nsv876769	chr3:50155468-50408398	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
6	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
7	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
8	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
9	nsv590251	chr3:50158774-50337422	Active TSS Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
10	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
11	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
12	nsv523560	chr3:50172397-50339163	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
13	nsv460529	chr3:50178011-50324672	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
14	nsv460530	chr3:50178011-50324672	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
15	nsv590252	chr3:50178011-50324672	Enhancers Bivalent Enhancer Strong transcription Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
16	nsv1002916	chr3:50187646-50311666	Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
17	nsv536564	chr3:50187646-50311666	Flanking Active TSS Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
18	nsv1014256	chr3:50187646-50339163	Enhancers Active TSS Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
19	nsv536565	chr3:50187646-50339163	Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
20	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
21	nsv590253	chr3:50196418-50337422	Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
22	esv2757870	chr3:50198478-50371377	Genic enhancers Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
23	esv2759148	chr3:50198478-50371377	Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
24	nsv834692	chr3:50198485-50393464	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
25	nsv590254	chr3:50243510-50388607	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
26	nsv460531	chr3:50247824-50436827	Strong transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
27	nsv590255	chr3:50247824-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
28	nsv876772	chr3:50255305-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
29	nsv590257	chr3:50302830-50393640	Genic enhancers Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	82 gene(s)	inside rSNPs	diseases
30	nsv590256	chr3:50302830-50420554	Weak transcription Enhancers Active TSS Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
31	nsv876774	chr3:50302830-50436827	Enhancers Strong transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
32	nsv876773	chr3:50302830-50480131	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
33	nsv834693	chr3:50302830-50507964	Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:79 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50302600-50309600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
2	chr3:50305600-50310600	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr3:50305800-50309800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
4	chr3:50306000-50309200	Enhancers	Fetal Lung	lung
5	chr3:50306000-50309400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr3:50306400-50310600	Weak transcription	Left Ventricle	heart
7	chr3:50306800-50316000	Weak transcription	Aorta	Aorta
8	chr3:50307000-50309200	Transcr. at gene 5' and 3'	Fetal Intestine Small	intestine
9	chr3:50307200-50309200	Enhancers	Ovary	ovary
10	chr3:50307200-50309200	Enhancers	Placenta Amnion	Placenta Amnion
11	chr3:50307200-50310600	Weak transcription	Right Atrium	heart
12	chr3:50307400-50310400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
13	chr3:50307600-50309200	Enhancers	Skeletal Muscle Female	skeletal muscle
14	chr3:50307600-50309200	Enhancers	A549	lung
15	chr3:50307600-50309400	Genic enhancers	Brain Dorsolateral Prefrontal Cortex	brain
16	chr3:50307600-50309400	Transcr. at gene 5' and 3'	Placenta	Placenta
17	chr3:50307600-50310400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
18	chr3:50307600-50310400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
19	chr3:50307800-50309200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
20	chr3:50307800-50309200	Enhancers	HMEC	breast
21	chr3:50307800-50309600	Enhancers	Adipose Nuclei	Adipose
22	chr3:50307800-50310400	Enhancers	Rectal Mucosa Donor 29	rectum
23	chr3:50307800-50310400	Weak transcription	Right Ventricle	heart
24	chr3:50307800-50310600	Weak transcription	Sigmoid Colon	Sigmoid Colon
25	chr3:50308000-50309400	Enhancers	NHLF	lung
26	chr3:50308000-50309600	Genic enhancers	Brain Hippocampus Middle	brain
27	chr3:50308000-50309600	Enhancers	Colonic Mucosa	Colon
28	chr3:50308000-50309600	Genic enhancers	Fetal Muscle Leg	muscle
29	chr3:50308000-50310400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr3:50308000-50310600	Weak transcription	Fetal Heart	heart
31	chr3:50308000-50310600	Weak transcription	Psoas Muscle	Psoas
32	chr3:50308200-50309200	Genic enhancers	Fetal Muscle Trunk	muscle
33	chr3:50308200-50309200	Genic enhancers	Pancreas	Pancrea
34	chr3:50308200-50309200	Flanking Active TSS	Hela-S3	cervix
35	chr3:50308200-50310400	Enhancers	Breast Myoepithelial Primary Cells	Breast
36	chr3:50308200-50310600	Enhancers	Fetal Kidney	kidney
37	chr3:50308200-50310600	Enhancers	Stomach Mucosa	stomach
38	chr3:50308400-50309200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr3:50308400-50309400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr3:50308400-50310200	Weak transcription	Muscle Satellite Cultured Cells	--
41	chr3:50308400-50310400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
42	chr3:50308400-50310400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr3:50308400-50310400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr3:50308400-50310400	Weak transcription	Colon Smooth Muscle	Colon
45	chr3:50308400-50310400	Weak transcription	HSMM	muscle
46	chr3:50308400-50310400	Weak transcription	NHEK	skin
47	chr3:50308400-50310400	Weak transcription	Osteobl	bone
48	chr3:50308400-50310600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
49	chr3:50308400-50310600	Weak transcription	NHDF-Ad	bronchial
50	chr3:50308600-50309400	Flanking Active TSS	Fetal Intestine Large	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links